Chemist Warehouse sales surge as Sigma merger looms
The retailer has reported rampaging sales figures, just a day before Sigma Healthcare shareholders are due to vote on a multi-billion dollar merger with the pharmacy retailer.
Victoria Business
EML Payments should be sold off, activist investor argues
Activist investor Jeremy Raper has written to the EML Payments board arguing that the company’s brand is beyond repair and it should kick off a sales process.
Strong gains tipped for drug developers in 2025
There’s a grab bag of Australian-listed drug developers that should be on investors’ radars this year, analysts say, with a hefty upside potentially on the cards.
Super funds back push for DEI reporting and boardroom quotas
As Donald Trump inflames the diversity, equity and inclusion debate in the US, super funds here reiterated their support for DEI reporting by ASX-listed companies.
More Stories
Breakthrough Victoria-funded med-tech enters administration
A Melbourne med-tech start-up at the centre of a court fight has fallen into administration, as the company’s co-founder lobbed a shot at Victoria’s $2bn venture capital fund.
Bondi Ponzi scheme promoter avoids jail time
David Sipina, who promoted the fraudulent Courtenay House Ponzi scheme which left creditors owed more than $50m, has avoided jail time after pleading guilty.
Cooper Investors offloads $41m of Incitec stock
Incitec Pivot says it will forge ahead with asset sales next year, while at the same time warning earnings will take a hit from investment in plant.
Barefoot Investor: ‘How I took on the fake Scott Pape scammers’
Barefoot Investor tried to uncover Facebook’s fake Scott Pape scammers but it all descended into chaos with his wife away, the kids sick and German backpackers running his farm.
ANZ’s board ignored a very loud message on bonuses
Qantas, Woolworths and now ANZ have all found out the hard way. On reputation – you go up slowly but come down at high speed.
Mesoblast turns 10-bagger on FDA approval
The company has received US Food and Drug Administration approval for its drug Ryoncil, in a stunning turnaround from a year ago, when the same drug tanked the share price.
Catholic hospitals blocked from private insurer boycott
Catholic Health Australia, whose members provide about a third of private hospital care nationally, will not be allowed to emulate Healthscope’s boycott of private health insurers.
The worrying warning sign behind Chalmers’ budget update
The commodity super-cycle is rapidly coming to an end, and Australia’s finances are nowhere near ready for this moment.
Insignia knocks back Bain approach
Insignia Financial has rejected Bain Capital’s $2.7bn takeover offer, described by its largest shareholder as “highly opportunistic”.
Circular economy could return billions with the right action
Australia can add $26bn to the economy over the next decade if it embraces circular economy principles, but there’s still plenty of work to do.
Original URL: https://www.adelaidenow.com.au/business/victoria-business/page/7